Kairos Pharma, LTD. Quarterly Common Stock, Shares, Outstanding from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kairos Pharma, LTD. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2023 to Q3 2024.
  • Kairos Pharma, LTD. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 12.8M shares.
Common Stock, Shares, Outstanding, Quarterly (shares)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.